Business Description
Baxter International Inc
NAICS : 339112
SIC : 3841
ISIN : US0718131099
Share Class Description:
BAX: Ordinary SharesCompare
Compare
Traded in other countries / regions
BAX.USA0QK8.UKBTL.GermanyBAX.Austria1BAX.ItalyBAX.MexicoB1AX34.BrazilBAX.Switzerland IPO Date
1961-05-15Description
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter has signed an agreement to sell its kidney care tools by early 2025.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.11 | |||||
| Equity-to-Asset | 0.3 | |||||
| Debt-to-Equity | 1.68 | |||||
| Debt-to-EBITDA | 8.65 | |||||
| Interest Coverage | 1.3 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2.16 | |||||
| Beneish M-Score | -2.65 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 9 | |||||
| 3-Year EBITDA Growth Rate | -9 | |||||
| 3-Year FCF Growth Rate | -3.1 | |||||
| 3-Year Book Growth Rate | -1.3 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 64.45 | |||||
| 9-Day RSI | 51.52 | |||||
| 14-Day RSI | 45.74 | |||||
| 6-1 Month Momentum % | 8.44 | |||||
| 12-1 Month Momentum % | -1.13 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.43 | |||||
| Quick Ratio | 1.09 | |||||
| Cash Ratio | 0.23 | |||||
| Days Inventory | 87.38 | |||||
| Days Sales Outstanding | 51.07 | |||||
| Days Payable | 37.48 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.09 | |||||
| Dividend Payout Ratio | 0.78 | |||||
| 3-Year Dividend Growth Rate | 6.7 | |||||
| Forward Dividend Yield % | 2.02 | |||||
| 5-Year Yield-on-Cost % | 4.98 | |||||
| 3-Year Average Share Buyback Ratio | -0.2 | |||||
| Shareholder Yield % | 22.14 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 33.42 | |||||
| Operating Margin % | 3.21 | |||||
| Net Margin % | 0.63 | |||||
| FCF Margin % | 2.26 | |||||
| ROE % | 1.34 | |||||
| ROA % | 0.39 | |||||
| ROIC % | 3.18 | |||||
| ROC (Joel Greenblatt) % | 3.11 | |||||
| ROCE % | 1.06 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 168.55 | |||||
| Forward PE Ratio | 13.42 | |||||
| PE Ratio without NRI | 22.72 | |||||
| Shiller PE Ratio | 11.33 | |||||
| PS Ratio | 0.99 | |||||
| PB Ratio | 2.19 | |||||
| Price-to-Free-Cash-Flow | 43.89 | |||||
| Price-to-Operating-Cash-Flow | 16.14 | |||||
| EV-to-EBIT | 126.03 | |||||
| EV-to-Forward-EBIT | 15.21 | |||||
| EV-to-EBITDA | 19.01 | |||||
| EV-to-Forward-EBITDA | 9.79 | |||||
| EV-to-Revenue | 1.68 | |||||
| EV-to-Forward-Revenue | 2.14 | |||||
| EV-to-FCF | 74.13 | |||||
| Price-to-Projected-FCF | 1 | |||||
| Price-to-Median-PS-Value | 0.33 | |||||
| Earnings Yield (Greenblatt) % | 0.79 | |||||
| FCF Yield % | 2.27 | |||||
| Forward Rate of Return (Yacktman) % | 10.62 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:BAX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Baxter International Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 17,282 | ||
| EPS (TTM) ($) | 0.2 | ||
| Beta | 0.77 | ||
| Volatility % | 23.93 | ||
| 14-Day RSI | 45.74 | ||
| 14-Day ATR ($) | 0.78595 | ||
| 20-Day SMA ($) | 33.701 | ||
| 12-1 Month Momentum % | -1.13 | ||
| 52-Week Range ($) | 31.6 - 44.005 | ||
| Shares Outstanding (Mil) | 510.59 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Baxter International Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Baxter International Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Baxter International Inc Frequently Asked Questions
What is Baxter International Inc(BAX)'s stock price today?
The current price of BAX is $33.71. The 52 week high of BAX is $44.01 and 52 week low is $31.60.
When is next earnings date of Baxter International Inc(BAX)?
The next earnings date of Baxter International Inc(BAX) is 2025-02-07 Est..
Does Baxter International Inc(BAX) pay dividends? If so, how much?
The Dividend Yield %  of Baxter International Inc(BAX) is 3.09% (As of Today), Highest Dividend Payout Ratio of Baxter International Inc(BAX) was 2.62. The lowest was 0.12. And the median was 0.45. The  Forward Dividend Yield % of Baxter International Inc(BAX) is 2.02%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers